Tuesday, June 13, 2023 3:16:19 PM
You played with the numbers the wrong way. Dr. Stupp's expertise is in the domain of chemo which will be made obsolete by DCVax-L sooner than expected.
Take a look at the type of research he is doing. Will any GBM patients try the treatment he was researching if DCVax-L is available? You should question if Dr. Stupp made the right judgement. But it seems like you were overwhelmed by the number of titles he carried over his shoulder.
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00112-2/fulltext
Recent NVCR News
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
